* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download NEED FOR THE STUDY Hypertension is the most important health
Management of acute coronary syndrome wikipedia , lookup
Saturated fat and cardiovascular disease wikipedia , lookup
Remote ischemic conditioning wikipedia , lookup
Heart failure wikipedia , lookup
Cardiac contractility modulation wikipedia , lookup
Mitral insufficiency wikipedia , lookup
Cardiac surgery wikipedia , lookup
Electrocardiography wikipedia , lookup
Cardiovascular disease wikipedia , lookup
Coronary artery disease wikipedia , lookup
Hypertrophic cardiomyopathy wikipedia , lookup
Echocardiography wikipedia , lookup
Myocardial infarction wikipedia , lookup
Quantium Medical Cardiac Output wikipedia , lookup
Ventricular fibrillation wikipedia , lookup
Antihypertensive drug wikipedia , lookup
Arrhythmogenic right ventricular dysplasia wikipedia , lookup
NEED FOR THE STUDY Hypertension is the most important health problem met by general physicians.LVH is one of the most important complications of hypertension. The development of left ventricular hypertrophy increases with the severity of hypertension and presence of increased left ventricular mass is associated with increased incidence of MI,CHF,STROKE other target organ damage.Hence LVH no longer considered as an adaptive mechanism that compensates the pressure imposed on the heart and has been identified as an independent and significant risk factor for sudden death ,acute MI ,CHF and stroke.1 The incidence of LVH is on the rise ,more alarmingly in developing countries. The Framingham heart study suggested that 1 in 10 persons will have LVH in the age 65to 69.2 Early detection and appropriate treatment decreases the development of left ventricular hypertrophy and reduces the mortality and morbidity.ECG, 2D ECHO and chest x-ray are different modalities for diagnosis of LVH.ECG and chest X-ray in the assessment of cardiac dimensions has lost its prominence in favour of 2D ECHO. Hence this study is undertaken to compare the diagnostic efficiency of these methods in diagnosing left ventricular hypertrophy because the best means of decreasing the increased mortality and morbidity is to prevent the development of left ventricular hypertrophy which requires early and continuous antihypertensive therapy even before the hypertrophy becomes clinically manifest.3 REVIEW OF LITERATURE The cardiovascular consequences of hypertension have long been appreciated. In 1913, the famous clinician Thomas Janeway described congestive heart failure as the manifestation of hypertensive cardiovascular disease4. Shortly after, the relationship between hypertension and hypertrophy of the left ventricle was established in observations linking cardiac findings to the then new technique of indirect blood pressure measurement with sphygmomanometry. In the Framingham heart Study,in 1990, it was shown that for each 50 g/m increase in LV mass (corrected for height) there was a relative risk for mortality of 1.73, even in subjects free of clinically apparent cardiovascular disease5. It was also demonstrated that this risk was statistically independent of blood pressure, age, antihypertensive treatment, and other cardiovascular risk factors. Devereux and Reicheck in 1981 were the first to co-relate ECHO LV mass estimates with LV specimens of same hearts at biopsy6.They tested various geometric formulas and different methods of measuring wall thickness and LVID and found that anatomic LV mass correlated best with LV measurements by Penn convention(r=0.96) using the following empirical equation: . LVmass=1.04[(IVST+LVID+PWT)3- LVID3]-13.6g Using the American Society of Echocardiography method of measuring septal and left ventricular wall thickness .Devereux and Woythaler et al., found a good correlation between ECHO and anatomic LVmass.7 AIMS AND OBJECTIVES To identify the left ventricular hypertrophy. Comparison of relative sensitivity, and specificity of echocardiogram, standard 12 lead ECG, and chest roentgenography for detecting left ventricular hypertrophy in essential hypertension. Correlation of left ventricular hypertrophy and target organ involvement in hypertensive patients. INCLUSION CRITERIA The study group will consisted of patients above the age of 40 year of both sexes. All freshly detected and old cases of essential hypertension, irrespective of duration of hypertension and type of treatment receiving will be taken into the study. EXCLUSION CRITERIA All cases of secondary hypertension. Patients with previous ischemic heart disease either myocardial infarction or ischemic cardiomyopathy. Patients with congenital heart disease and Patients with valvular heart disease MATERIALS AND METHODS SOURCE OF DATA Study will be carried out in SRI ADICHUNCHANGIRI INSTITUTE OF MEDICAL SCIENCE AND RESEARCH CENTRE,B.G.Nagar from November 2010 to April 2012. METHOD OF COLLECTION OF DATA The study group will consist of 50 patients of both sexes with essential hypertension attending the outpatient clinic as well as those admitted in medical wards. Thorough history,physical examination, chest X-ray, standard 12 lead ECG and two dimensional echocardiography will be done for all patients . The following clinical information will be obtained, apart from investigations. 1. Duration of hypertension, <5 years, 6-10 years, > 11 years. 2. Number and type of antihypertensive drugs . 3.Standard cuff blood pressure in supine and standing . 4. Body surface area 5. Cardiovascular examination: Site and character of apical impulse Character of heart sounds Presence of abnormal heart sounds and murmurs. 6. H/O stroke or recurrent transient cerebral ischemia. STATISTICAL TESTS: 1)Diagnostic validity tests 2)Kappa measure of agreement 3)Chi-square test. Does the study require any investigations or interventions to be conducted on patients or other humans or animals? If so describe briefly? YES Investigations: Routine investigations: Fasting Blood Sugar B. Urea S. Creatinine Fasting lipid profile Urine - Albmin - Sugar Ophthalmic examination for any evidence of hypertensive retinopathy Specific investigations: Chest X-ray: PA view- to measure cardiothoracic ratio Standard 12 lead ECG 2D ECHOCARDIOGRAPHY LIST OF REFERENCES 1)Devereux R.B.”Does increased blood pressure cause left ventricular hypertrophy or vice versa”. Annals of internal medicine, 2000; 112:57-8. 2) Friedman AJ ET. Al.”Accuracy of M mode echocardiographic measurements of left ventricle.”Am J Cardiol 1982:99:716-720 3)Edward D.Frolich.The pathophysiology of systemic arterial hypertension.In Hurst’s The Heart,edt.by Wayne Alexander, Robert C.Schalant, Valentine Fuster,8th edition,New York,Mc Graw –Hill Companies:1992:1393 4) Janeway TC. A clinical study of hypertensive cardiovascular disease. Arch Intern Med 1913; 12: 755. 5) Levy D, Garrison RH, Savage DD. Prognostic implications of echocardiographically determined LV mass in The Framingham Heart Study. N Engl J Med 1990; 322: 1561-1566. 6)Devereux R.B.,Alonso D.R.,Lutas E.M.,Echocardiographic assessment of LVH comparison to necropsy findings.Am J Cardiol 1986;57:450-458 7) Devereux R.B.,”Detection of LVH by M-mode echocardiography”Hypertension, 1987, 9:19-23 8)Nathaniel Reichek, Richard B. Devereux. Left ventricular hypertrophy relationship of anatomic, echocardiographic, electrocardiographic findings. Circulation 1981; 83: 13911398. 9) M. Paul Anand. Essential Hypertension, Chapter 19, 8th edition, Siddarth N. Shah, M. Paul Anand. 2008, API Text book of medicine. Vidya N. Acharya, S.K. Bichile, Y.D. Munjal, Dilip R. Karnad et al 531-540. 10) Naomi DL Fisher, Gordon H. Williams. Hypertensive vascular disease. In Harrison’s Principles of internal medicine edited by Dennis. L. Kasper, Anthony S. Fauci, Dan L. Longo Eugene Braunwald, Stephen L. Hauser, J. Larry Jameson, 17thedition, NewYork, McGraw-Hill Companies, 2008:1549-1562. 11)Cohen A, Hagen AD, Watkins J. Clinical correlates in hypertensive patients with LVH diagnosed with echocardiography. Am J Cardiiol 1981; 47: 335-341. 12)Richard B.Devereux,Paul N Casale,Richard R Eisenburg,David H Miller,Paul Kligfield.Electrocardiographic detection of left ventricular hypertrophy using echocardiogrphic determination of left ventricular mass as reference the reference standard.JACC vol 3,no 1,Jan 1984 82-87 .13)Paolo Verdecchia,Giuseppe Schillaci,Claudia Borgioni,Antonella Ciucci, Roberto Gattobigio, Ivano Zampi, Gianpaolo Reboldi, Carlo Porcelatti.Prognostic significance of serial changes in left ventricular mass in essential hypertension.Circulation, 1998; 97:48-54. 14) Richard S. Crow, Ronald J Prineas, Penni Rautahraju, Peter Hannan, Phillip R Liebson.Relation between Electrocardiogrphy and echocardiography For left ventricular mass in mild systemic hypertension.The American Journal of cardiology.vol 75,1995,1233-1238 15) WS Post, MG Larson and D Levy. Impact of left ventricular structure on the incidence of hypertension. The Framingham Heart Study Circulation 1994; 90; 179-185 16) Murilo Foppa, 1 Bruce B Duncan, 1 and Luis EP Rohde1. Echocardiography-based left ventricular mass estimation. How should we define hypertrophy? Cardiovasc Ultrasound. 2005; 3: 17 17)Johan Sundström, Lars Lind, Johan Ärnlöv, Björn Zethelius, Bertil Andrén and Hans O. Lithell Echocardiographic and Electrocardiographic Diagnoses of Left Ventricular Hypertrophy Predict Mortality Independently of Each Other in a Population of Elderly Men .Circulation 2001; 103; 2346-2351 18) Franz H. Messerli, Franz C, Aepfelbacher. Cardiology Clinics. 1995 November.:549. 19)Heidi M.,Connoly,Jae.K.Oh.”Echocardiography”,Braunwald’s heart disease.A text book of cardiovascular medicine,2008,8th edt.:245-246.